Medullary thyroid carcinoma cell lines contain a self-renewing CD133 + population that is dependent on Ret proto-oncogene activity

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 1, 2010, Pages 439-444

  Zhu, Wen ^a   Hai, Tao ^a   Ye, Lei ^a   Cote, Gilbert J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA TUBULIN; BETA TUBULIN 3; CD133 ANTIGEN; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; PROTEIN RET; UNCLASSIFIED DRUG;

ARTICLE; CANCER STEM CELL; CELL RENEWAL; CELL SHAPE; CELL SUBPOPULATION; CONTROLLED STUDY; GENE ACTIVATION; GENE ACTIVITY; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; NEURAL STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTO ONCOGENE; RNA INTERFERENCE; STEM CELL EXPANSION; THYROID MEDULLARY CARCINOMA;

EID: 75149138258     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-1485     Document Type: Article

References (20)

1. Dick JE 2003 Breast cancer stem cells revealed. Proc Natl Acad Sci USA 100:3547-3549
2. Passegue E, Jamieson CH, Ailles LE, Weissman IL 2003 Normal and leukemic hematopoiesis: are leukemias a stem cell disorder or a reacquisition of stem cell characteristics? Proc Natl Acad Sci USA 100(Suppl 1):11842-11849
3. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, Dirks PB 2003 Identification of a cancer stem cell in human brain tumors. Cancer Res 63:5821-5828
4. Dietrich J, Imitola J, Kesari S 2008 Mechanisms of disease: the role of stem cells in the biology and treatment of gliomas. Nat Clin Pract Oncol 5:393-404
5. Wu Y, Wu PY 2 May 2009 CD133 as a marker for cancer stem cells: progresses and concerns. Stem Cells Dev 10.1089/scd.2008.0338
6. Schlumberger M, Carlomagno F, Baudin E, Bidart JM, Santoro M 2008 New therapeutic approaches to treat medullary thyroid carcinoma. Nat Clin Pract Endocrinol Metab 4:22-32
7. Messina M, Robinson BG 2007 Technology insight: gene therapy and its potential role in the treatment of medullary thyroid carcinoma. Nat Clin Pract Endocrinol Metab 3:290-301
8. Wohllk N, Cote GJ, Bugalho MM, Ordonez N, Evans DB, Goepfert H, Khorana S, Schultz P, Richards CS, Gagel RF 1996 Relevance of RET proto-oncogene mutations in sporadic medullary thyroid carcinoma. J Clin Endocrinol Metab 81:3740-3745
9. Bruno IG, Jin W, Cote GJ 2004 Correction of aberrant FGFR1 alternative RNA splicing through targeting of intronic regulatory elements. Hum Mol Genet 13:2409-2420
10. Lee G, Kim H, Elkabetz Y, Al Shamy G, Panagiotakos G, Barberi T, Tabar V, Studer L 2007 Isolation and directed differentiation of neural crest stem cells derived from human embryonic stem cells. Nat Biotechnol 25:1468-1475
11. Heanue TA, Pachnis V 2007 Enteric nervous system development and Hirschsprung's disease: advances in genetic and stem cell studies. Nat Rev Neurosci 8:466-479
12. Hoelzinger DB, Demuth T, Berens ME 2007 Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment. J Natl Cancer Inst 99:1583-1593
13. Santoro M, Carlomagno F, Romano A, Bottaro DP, Dathan NA, Grieco M, Fusco A, Vecchio G, Matoskova B, Kraus MH, Di Fiore PP 1995 Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B. Science 267:381-383
14. Eramo A, Lotti F, Sette G, Pilozzi E, Biffoni M, Di Virgilio A, Conticello C, Ruco L, Peschle C, De Maria R 2008 Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 15:504-514
15. Iwashita T, Kruger GM, Pardal R, Kiel MJ, Morrison SJ 2003 Hirschsprung disease is linked to defects in neural crest stem cell function. Science 301:972-976
16. Meng X, Lindahl M, Hyvönen ME, Parvinen M, de Rooij DG, Hess MW, Raatikainen-Ahokas A, Sainio K, Rauvala H, Lakso M, Pichel JG, Westphal H, Saarma M, Sariola H 2000 Regulation of cell fate decision of undifferentiated spermatogonia by GDNF. Science 287:1489-1493
17. Naughton CK, Jain S, Strickland AM, Gupta A, Milbrandt J 2006 Glial cell-line derived neurotrophic factor-mediated RET signaling regulates spermatogonial stem cell fate. Biol Reprod 74:314-321
18. Lindahl M, Timmusk T, Rossi J, Saarma M, Airaksinen MS 2000 Expression and alternative splicing of mouse Gfra4 suggest roles in endocrine cell development. Mol Cell Neurosci 15:522-533
19. Santarpia L, Ye L, Gagel RF 2009 Beyond RET: potential therapeutic approaches for advanced and metastatic medullary thyroid carcinoma. J Intern Med 266:99-113
20. Ezzat S, Huang P, Dackiw A, Asa SL 2005 Dual inhibition of RET and FGFR4 restrains medullary thyroid cancer cell growth. Clin Cancer Res 11:1336-1341